Market Cap

Biodesix, Inc. Market Capitalization:

$51.7 Million

USD as of Jan. 1, 2026

business Biodesix, Inc. Company Profile

Biodesix, Inc. Main Stock Listing

NASDAQ: BDSX

Market Capitalization History of Biodesix, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Biodesix, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $51.7 M -68.56%
Jan. 1, 2025 $164.4 M -7.78%
Jan. 1, 2024 $178.2 M 4.49%
Jan. 1, 2023 $170.6 M -40.10%
Jan. 1, 2022 $284.8 M -83.50%
Jan. 1, 2021 $1.73 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Biodesix, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Biodesix, Inc. has the following listings and related stock indices.


Stock: NASDAQ: BDSX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.